查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011148

植入式醫療設備市場：依產品類型、材料、應用和最終用戶分類－2026-2032年全球市場預測

Implantable Medical Device Market by Product Type, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，植入式醫療設備市場價值將達到 887.8 億美元，到 2026 年將成長至 950.4 億美元，到 2032 年將達到 1,465.6 億美元，複合年成長率為 7.42%。

主要市場統計數據
基準年 2025 887.8億美元
預計年份：2026年 950.4億美元
預測年份 2032 1465.6億美元
複合年成長率 (%) 7.42%

一份全面的策略概述，闡述了植入式醫療設備的意圖、範圍、相關人員的優先事項以及指導經營團隊決策的關鍵主題。

本執行摘要旨在提供關於植入式醫療設備產業的系統性、實證觀點，為董事會層面的策略制定、產品開發優先排序和產業計畫提供支援。摘要概述了影響決策的關鍵主題——技術融合、監管複雜性、採購趨勢和不斷演變的臨床路徑——並重點闡述了創新與實用化挑戰之間的相互作用。引言部分概述了報告的分析方法，明確了主要讀者，並闡述瞭如何利用所獲得的洞見來支持短期項目選擇和長期產品組合最佳化。

在植入式醫療設備的整體創新格局中，快速的變革和技術應用正在重塑臨床實踐、監管方法和供應鏈韌性。

在技​​術創新、監管力度加大以及臨床醫生期望不斷提高的推動下，植入式醫療設備領域正經歷著快速變革。尖端材料和微型電子元件催生出集感測、驅動和連接功能於一體的新型器械，而影像和外科手術技術的同步進步則拓展了介入治療的範圍。同時，監管機構日益關注上市後監管、網路安全要求和人因工程檢驗，凸顯了可靠的臨床證據和生命週期管理的重要性。

評估 2025 年美國關稅措施對製造業、籌資策略、跨境合作以及醫療設備供應的累積影響。

2025年影響跨境貿易和關稅體系的政策變化將對植入式醫療設備的製造商、供應商和買家產生重大影響。關稅調整正在改變全球供應鏈的成本結構，迫使採購團隊重新評估其採購區域，並將近岸外包和本地採購作為傳統集中式模式的替代方案。這些決策將影響與供應商的談判、庫存策略以及在投資本地生產能力和維護全球供應商關係之間的權衡。

關鍵細分洞察揭示了整個醫療保健服務環境中，不同產品、材料成分、臨床應用和最終用戶環境的不同需求模式。

細分市場洞察揭示了不同產品類型、材料、應用和終端用戶環境的需求特徵和發展重點，有助於制定產品組合和上市時間策略。產品層面的差異化至關重要。心臟植入，例如去心房顫動和心律調節器，需要嚴格的可靠性、長期遙測功能以及強調耐用性和遠端監測的監管途徑。美容植入，包括乳房和臉部植入，優先考慮生物相容性材料和美學效果，而美學效果取決於患者的偏好和外科醫生的技術。牙科植入需要精確的材料和表面工程技術，以促進骨整合，並直接與修復工作流程相銜接。神經系統植入需要超低延遲的電子元件和高度密封的封裝，以滿足精密神經系統應用的需求。眼科植入必須符合微米級公差和眼科安全標準。整形外科植入，包括髖關節和膝關節植入，則著重於承重材料和成熟的手術器械。基於材料的細分（陶瓷、金屬、聚合物）會在耐磨性、耐腐蝕性、成像相容性和組織反應等方面造成性能上的權衡，從而影響器械的選擇和臨床通訊協定。基於應用領域的細分（例如心臟病學、整形外科、牙科、神經病學和整形外科）則進一步指導臨床證據的製定和報銷策略，因為每個應用領域都展現出獨特的療效指標和部署路徑。最終使用者（例如手術中心、診所、醫院）的採購週期、手術量和資金限制各不相同，這些因素共同決定了採購決策以及服務和支援需求。整合這些細分觀點有助於更細緻地進行產品和市場匹配決策、臨床試驗優先排序，並建構反映各醫療環境實際營運的客製化商業模式。

戰略區域洞察，重點關注美洲、歐洲、中東和非洲以及亞太市場的需求推動要素、監管細微差別和採用障礙。

區域差異持續顯著影響植入式醫療設備的監管流程、報銷途徑和部署計畫。美洲市場擁有成熟的臨床生態系統、完善的報銷機制和龐大的手術量，對於能夠展現明確臨床和經濟價值的高階器械而言，是一個極具吸引力的市場。相較之下，歐洲、中東和非洲（EMEA）的監管環境則呈現出異質性，區域協調的努力與各國特有的報銷流程並存，這既為差異化參與策略創造了機遇，也為證據一致性帶來了挑戰。亞太地區正經歷基礎設施的快速擴張、訓練有素的專家數量的增加以及政府主導的旨在加強醫療體系的舉措，所有這些因素都促進了新型外科技術的應用。然而，價格敏感度依然很高，各地區的監管進度也存在差異。

對領先醫療設備製造商的策略組合、合作夥伴網路、智慧財產權重點和業務重點進行公司層面的競爭考察。

植入式醫療設備生態系統中的主要企業正透過策略性的產品組合選擇、合作夥伴關係以及注重生命週期管理和臨床證據產生的業務投資來實現差異化競爭。一些製造商正在加強其在相關服務領域的能力，例如遠端監測平台、上市後監測數據分析以及外科醫生培訓解決方案，從而打造能夠改善患者預後並建立臨床工作流程的整合提案。另一些製造商則專注於提升其核心產品的性能和製造程序，透過投資品質系統和先進材料工程來贏得臨床醫生的信任並降低再次手術率。

為行業領導者提供可操作的營運建議，以加速創新、最佳化供應鏈、加強合規性並快速改善以患者為中心的治療效果。

行業領導者應優先採取一系列切實可行的措施，以克服當前不利因素並抓住新的機會。首先，將研發與臨床證據項目結合，提供能夠引起臨床醫師和支付方共鳴的療效指標，確保設計選擇能夠預見實際應用和報銷標準。其次，透過供應商多元化、認證區域生產合作夥伴以及實施庫存緩衝策略來增強供應鏈韌性，從而減輕關稅和物流衝擊。第三，投資可互通的數位平台和安全遙測技術，以提升醫療設備的價值提案，並滿足日益成長的遠端監控和網路安全需求。

嚴謹的調查方法，明確定義資料來源、相關人員參與、定性和定量檢驗程序以及分析框架。

本報告的調查方法結合了系統性的證據收集、相關人員對話和交叉檢驗，確保了結論的可靠性和可操作性。主要資訊來源包括對臨床醫生、採購經理和技術專家的結構化訪談，以及對臨床現場的考察，以觀察工作流程互動和醫療設備操作注意事項。次要資訊來源包括同儕審查的臨床文獻、監管指導文件和技術標準，這些資料有助於評估材料性能、安全性和生命週期管理實踐。

簡明扼要的結論，整合了戰略意義、新興風險因素以及臨床、製造和政策領域相關人員的優先行動。

總之，我們總結了參與植入式醫療設備開發、商業化和採購的相關人員所面臨的策略挑戰。儘管新興技術和材料科學的進步拓展了臨床應用的可能性，但從創新到永續應用的路徑取決於一項整合臨床證據、監管前瞻性和供應鏈穩健性的綜合策略。相關人員必須在快速上市和全面的風險管理之間取得平衡，尤其是在網路安全、上市後監測和人為因素等領域，因為這些因素對監管機構的批准和臨床醫生的信心的影響日益增強。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：植入式醫療設備市場：依產品類型分類

  • 心臟植入
    • 去心房顫動
    • 心律調節器
  • 美容植入
    • 植入
    • 臉部植入
  • 植入
  • 神經植入
  • 眼科植入
  • 整形外科植入
    • 髖關節植入
    • 膝關節植入

第9章：植入式醫療設備市場：依材料分類

  • 陶瓷製品
  • 金屬
  • 聚合物

第10章：植入式醫療設備市場：依應用領域分類

  • 循環系統
  • 美容護理
  • 牙科
  • 神經病學
  • 整形外科

第11章：植入式醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章：植入式醫療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：植入式醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：植入式醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國植入式醫療設備市場

第16章：中國植入式醫療設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cochlear Limited
  • Cook Medical Incorporated
  • Dentsply Sirona Inc.
  • Edwards Lifesciences Corporation
  • Fresenius SE & Co. KGaA
  • Getinge AB
  • Globus Medical, Inc.
  • Integer Holdings Corporation
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic plc
  • NuVasive, Inc.
  • Smith & Nephew plc
  • Straumann Holding AG
  • Stryker Corporation
  • Terumo Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4355714631BF

The Implantable Medical Device Market was valued at USD 88.78 billion in 2025 and is projected to grow to USD 95.04 billion in 2026, with a CAGR of 7.42%, reaching USD 146.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 88.78 billion
Estimated Year [2026] USD 95.04 billion
Forecast Year [2032] USD 146.56 billion
CAGR (%) 7.42%

Comprehensive strategic introduction that frames the intent, scope, stakeholder priorities, and major themes guiding executive decisions in implantable devices

This executive summary introduces a structured, evidence-driven perspective on the implantable medical device arena, intended to inform board-level strategy, product development priorities, and operational planning. It frames the principal themes that influence decision-making-technology convergence, regulatory complexity, procurement dynamics, and evolving clinical pathways-while highlighting the interplay between innovation and practical deployment challenges. The introduction situates readers to the report's analytical approach, clarifies intended audiences, and outlines how insights can be mobilized to support near-term program choices and longer-term portfolio rationalization.

By establishing a clear problem statement and defining the strategic questions addressed, the introduction creates a common baseline for interpretation. It emphasizes how clinical outcomes, supply chain structure, and reimbursement environments jointly determine adoption trajectories for implantable devices. Consequently, readers gain a precise orientation that links technical performance and material selection to institutional purchasing behavior and clinician acceptance, enabling more targeted follow-through across clinical, regulatory, and commercial functions.

Rapid transformative shifts and technology adoption dynamics reshaping clinical practice, regulatory approaches, and supply chain resilience across implantable medical innovations

The landscape for implantable devices is undergoing rapid transformation driven by technological innovation, intensified regulatory scrutiny, and evolving clinician expectations. Advanced materials and miniaturized electronics are enabling new classes of devices that blend sensing, actuation, and connectivity, while concurrent progress in imaging and surgical techniques is expanding the range of feasible interventions. At the same time, regulators are increasing emphasis on post-market surveillance, cyber-security requirements, and human factors validation, which elevates the importance of robust clinical evidence and lifecycle management.

Supply chain dynamics have shifted toward resilience and geographic diversification, prompting manufacturers to reconsider sourcing strategies and increase collaboration with contract manufacturers and specialized suppliers. Payer and provider ecosystems are demanding stronger proof of value and patient-centered outcomes, which in turn influences product design and commercialization plans. These converging shifts mean that companies must align R&D, regulatory, and market access functions more tightly than before, and they must adopt more agile operational models to translate technical advances into durable clinical adoption and sustainable commercial returns.

Assessment of the cumulative implications of United States tariff measures in 2025 on manufacturing, procurement strategies, cross-border collaboration, and device availability

Policy changes affecting cross-border trade and tariff regimes in 2025 have generated material implications for manufacturers, suppliers, and purchasers of implantable devices. Tariff adjustments have altered cost structures across global supply chains, prompting procurement teams to reassess sourcing geographies and to evaluate nearshoring or regional sourcing as alternatives to previously centralized models. These decisions affect supplier negotiations, inventory strategies, and the calculus for investing in local production capability versus maintaining global supplier relationships.

Consequently, companies are revisiting total landed cost analyses and supplier risk profiles to understand the cumulative impact on product availability and production lead times. Clinical providers are also reassessing tender cycles and device selection criteria to mitigate exposure to price volatility and potential disruptions. Beyond immediate operational changes, tariff-driven shifts are encouraging more strategic collaboration between manufacturers and health systems, including multi-year agreements and joint planning for capacity buffers. Through these responses, stakeholders aim to preserve clinical continuity while adapting commercial models to a more complex international trade environment.

Key segmentation insights that reveal differential demand patterns by product, material composition, clinical application, and end-user settings across care delivery environments

Segmentation insights reveal distinct demand profiles and development priorities across product types, materials, applications, and end-user settings that inform portfolio and go-to-market strategies. Product-level differentiation is pronounced: cardiac implants such as defibrillators and pacemakers require stringent reliability, long-term telemetry, and regulatory pathways that emphasize durability and remote monitoring; cosmetic implants including breast and facial implants prioritize biocompatible materials and aesthetic outcomes driven by patient preference and surgeon technique; dental implants interface directly with restorative workflows and demand precision materials and surface engineering to enhance osseointegration; neural implants require ultra-low latency electronics and hermetic packaging to support sensitive neurologic applications; ophthalmic implants must satisfy micro-scale tolerances and ophthalmologic safety standards; and orthopedic implants including hip and knee implants focus on load-bearing materials and proven surgical instrumentation. Materials segmentation-ceramic, metal, and polymer-shapes performance trade-offs for wear, corrosion resistance, imaging compatibility, and tissue response, influencing both device selection and clinical protocols. Application-based segmentation across cardiology, cosmetic procedures, dentistry, neurology, and orthopedics further guides clinical evidence development and reimbursement positioning because each application area presents unique outcome metrics and adoption pathways. End users-ambulatory surgical centers, clinics, and hospitals-exhibit differing procurement cycles, procedural volumes, and capital constraints, which together determine purchasing levers and service-support needs. Integrating these segmentation lenses enables more granular product-market fit decisions, prioritization of clinical trials, and tailored commercial models that reflect the operational realities of each care environment.

Strategic regional insights focusing on demand drivers, regulatory nuances, and adoption barriers across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional differences continue to exert substantial influence on regulatory processes, reimbursement pathways, and adoption timelines for implantable devices. The Americas market combines a mature clinical ecosystem with established reimbursement frameworks and high procedural volumes, making it attractive for premium devices that can demonstrate clear clinical and economic value. In contrast, Europe, Middle East & Africa presents a heterogeneous regulatory landscape where regional harmonization initiatives coexist with country-specific reimbursement processes, creating both opportunities for differentiated entry strategies and challenges in evidentiary alignment. Asia-Pacific demonstrates rapid infrastructure expansion, an increasing number of trained specialists, and government-led initiatives to upgrade healthcare capacity, which together support faster uptake of new surgical technologies, albeit with greater price sensitivity and variable regulatory timetables.

These regional dynamics have practical implications for regulatory submissions, post-market surveillance expectations, and commercial prioritization. Companies often sequence launches to align with reimbursement readiness and clinical champion availability, while tailoring messaging and pricing strategies to local procurement norms. Strategic regional partnerships and adaptive market access approaches are essential to balance global product standardization with local customization needs, enabling scalable yet regionally effective deployment plans.

Competitive company-level insights highlighting strategic portfolios, collaboration networks, intellectual property focus, and operational priorities among leading device manufacturers

Leading companies in the implantable device ecosystem are differentiating through strategic portfolio choices, alliances, and operational investments that emphasize lifecycle management and clinical evidence generation. Some manufacturers are deepening capabilities in adjacent service offerings-such as remote monitoring platforms, data analytics for post-market surveillance, and surgeon training solutions-to create integrated propositions that improve patient outcomes and lock in clinical workflows. Others concentrate on core device performance and manufacturing excellence, investing in quality systems and advanced materials engineering to secure clinical trust and reduce revision rates.

Competitive dynamics also reveal varied approaches to intellectual property and collaborative models: partnerships with academic centers and technology firms accelerate innovation cycles, while selective acquisitions fill capability gaps in electronics, biomaterials, or software. Operational priorities include modular design for manufacturability, validation of supply chain traceability, and building regulatory pathways that anticipate tightening standards for cybersecurity and human factors. For decision-makers, the implication is clear: competitive advantage now stems from a blend of technical differentiation, integrated service models, and the ability to demonstrate sustained clinical value through rigorous evidence and post-market follow-up.

Actionable, operational recommendations for industry leaders to accelerate innovation, optimize supply chains, strengthen compliance, and enhance patient-centric outcomes rapidly

Industry leaders should prioritize a set of pragmatic, executable actions to navigate current headwinds while capturing emerging opportunities. First, align R&D and clinical evidence programs to deliver outcome measures that resonate with both clinicians and payers, ensuring that design choices anticipate real-world use conditions and reimbursement criteria. Second, strengthen supply chain resilience by diversifying suppliers, qualifying regional production partners, and implementing inventory-buffer strategies that mitigate tariff and logistics shocks. Third, invest in interoperable digital platforms and secure telemetry to enhance device value propositions and meet rising expectations for remote monitoring and cybersecurity.

Additionally, foster deeper collaboration with provider networks through pilot programs, surgeon training, and shared risk arrangements that accelerate adoption and generate practical real-world data. Reassess pricing and contracting strategies to reflect total cost of care and long-term outcome benefits rather than unit price alone. Finally, integrate regulatory strategy into early-stage design decisions to reduce time to approval and simplify post-market obligations. Executed together, these recommendations create a cohesive pathway from innovation to deployment that balances speed, compliance, and clinical impact.

Rigorous research methodology delineating data sourcing, stakeholder engagement, qualitative and quantitative validation steps, and analytical frameworks

The research methodology underpinning this report combines systematic evidence collection, stakeholder engagement, and cross-validation to ensure robust, actionable findings. Primary inputs included structured interviews with clinicians, procurement leaders, and technical experts, alongside site visits to procedural settings to observe workflow interactions and device handling considerations. Secondary inputs comprised peer-reviewed clinical literature, regulatory guidance documents, and technical standards that informed assessment of material performance, safety considerations, and lifecycle management practices.

Analytical steps involved synthesis of qualitative insights with device- and application-specific technical assessments to identify critical success factors and adoption barriers. Validation occurred through triangulation of stakeholder perspectives and review panels with independent clinical advisors. Throughout, an emphasis on transparency in data sources, methodological assumptions, and conflict-of-interest disclosures supports the credibility of conclusions. This layered methodology ensures that recommendations are grounded in both clinical reality and technical feasibility, enabling pragmatic translation into strategic initiatives.

Concise conclusion synthesizing strategic implications, emergent risk vectors, and priority actions for stakeholders across clinical, manufacturing, and policy domains

The concluding synthesis draws together strategic imperatives for stakeholders engaged in implantable device development, commercialization, and procurement. Emerging technologies and material science advances expand clinical possibilities, but the pathway from innovation to sustained adoption depends on integrated strategies that combine clinical evidence, regulatory foresight, and supply chain robustness. Stakeholders must balance speed-to-market with comprehensive risk management-particularly in areas such as cybersecurity, post-market surveillance, and human factors-because these domains increasingly govern regulatory acceptability and clinician confidence.

In practical terms, organizations that unify product design, clinical engagement, and commercial planning will be better positioned to secure durable adoption and deliver measurable patient benefits. The report underscores the importance of regional strategy, targeted segmentation, and collaborative partnerships to overcome cost pressures and policy-driven complexities. By translating these strategic insights into prioritized action plans, leaders can reduce implementation friction and seize opportunities to improve outcomes across clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Implantable Medical Device Market, by Product Type

  • 8.1. Cardiac Implants
    • 8.1.1. Defibrillator
    • 8.1.2. Pacemaker
  • 8.2. Cosmetic Implants
    • 8.2.1. Breast Implants
    • 8.2.2. Facial Implants
  • 8.3. Dental Implants
  • 8.4. Neural Implants
  • 8.5. Ophthalmic Implants
  • 8.6. Orthopedic Implants
    • 8.6.1. Hip Implants
    • 8.6.2. Knee Implants

9. Implantable Medical Device Market, by Material

  • 9.1. Ceramic
  • 9.2. Metal
  • 9.3. Polymer

10. Implantable Medical Device Market, by Application

  • 10.1. Cardiology
  • 10.2. Cosmetic Procedures
  • 10.3. Dentistry
  • 10.4. Neurology
  • 10.5. Orthopedics

11. Implantable Medical Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Implantable Medical Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Implantable Medical Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Implantable Medical Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Implantable Medical Device Market

16. China Implantable Medical Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Baxter International Inc.
  • 17.7. Becton, Dickinson and Company
  • 17.8. Boston Scientific Corporation
  • 17.9. Cardinal Health, Inc.
  • 17.10. Cochlear Limited
  • 17.11. Cook Medical Incorporated
  • 17.12. Dentsply Sirona Inc.
  • 17.13. Edwards Lifesciences Corporation
  • 17.14. Fresenius SE & Co. KGaA
  • 17.15. Getinge AB
  • 17.16. Globus Medical, Inc.
  • 17.17. Integer Holdings Corporation
  • 17.18. Integra LifeSciences Holdings Corporation
  • 17.19. Johnson & Johnson Services, Inc.
  • 17.20. LivaNova PLC
  • 17.21. Medtronic plc
  • 17.22. NuVasive, Inc.
  • 17.23. Smith & Nephew plc
  • 17.24. Straumann Holding AG
  • 17.25. Stryker Corporation
  • 17.26. Terumo Corporation
  • 17.27. Wright Medical Group N.V.
  • 17.28. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DEFIBRILLATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PACEMAKER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY BREAST IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY FACIAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEURAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY DENTISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 155. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 156. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 179. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 180. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 181. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 187. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 188. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 189. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY CARDIAC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY COSMETIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA IMPLANTABLE MEDICAL DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)